Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Guidelines for managing Alzheimer's disease: Part II. Treatment.

Cummings JL, Frank JC, Cherry D, Kohatsu ND, Kemp B, Hewett L, Mittman B.

Am Fam Physician. 2002 Jun 15;65(12):2525-34. Review.

2.

Current treatments for Alzheimer's disease: cholinesterase inhibitors.

Doody RS.

J Clin Psychiatry. 2003;64 Suppl 9:11-7. Review.

3.

[Drug therapy strategies in Alzheimer's disease].

Lacomblez L.

Rev Prat. 1998 Nov 1;48(17):1913-7. French.

PMID:
9854394
4.

New therapeutic approaches to Alzheimer's disease.

Schneider LS.

J Clin Psychiatry. 1996;57 Suppl 14:30-6. Review.

PMID:
9024334
5.
7.

Cholinesterase inhibitors in Alzheimer's disease: donepezil or rivastigmine?

Sharma JC.

Int J Clin Pract. 2002 Jul-Aug;56(6):414-5. No abstract available.

PMID:
12166537
8.

Clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for Alzheimer's disease. A systematic review.

Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.

Int J Technol Assess Health Care. 2002 Summer;18(3):497-507. Review.

PMID:
12391943
9.

Realistic expectations for treatment success in Alzheimer's disease.

Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, Banerjee S, Lin P, Sano M.

J Nutr Health Aging. 2006 Sep-Oct;10(5):417-29. Review.

PMID:
17066215
10.

Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness.

Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y.

Clin Ther. 2002 Jun;24(6):862-86; discussion 837. Review.

PMID:
12117079
11.

Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.

Crismon ML.

Pharmacotherapy. 1998 Mar-Apr;18(2 Pt 2):47-54; discussion 79-82. Review.

PMID:
9543465
12.

Medications for the treatment of Alzheimer's disease.

Lampley-Dallas VT.

J Okla State Med Assoc. 2001 Aug;94(8):347-9.

PMID:
11515383
13.

Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.

Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG.

Curr Med Res Opin. 2003;19(8):707-14. Review.

PMID:
14687441
14.

Donepezil in severe Alzheimer's disease.

Winblad B.

Am J Alzheimers Dis Other Demen. 2009 Jun-Jul;24(3):185-92. doi: 10.1177/1533317509332094. Review.

PMID:
19246572
15.
17.

Cholinesterase inhibitors stabilize Alzheimer's disease.

Giacobini E.

Ann N Y Acad Sci. 2000;920:321-7. Review.

PMID:
11193171
18.

Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine.

Suh DC, Arcona S, Thomas SK, Powers C, Rabinowicz AL, Shin H, Mirski D.

Drugs Aging. 2004;21(6):395-403.

PMID:
15084141
19.

Acetylcholinesterase inhibition in Alzheimer's Disease.

Ibach B, Haen E.

Curr Pharm Des. 2004;10(3):231-51. Review.

PMID:
14754384
20.

What are the treatment options for patients with severe Alzheimer's disease?

Voisin T, Reynish E, Portet F, Feldman H, Vellas B.

CNS Drugs. 2004;18(9):575-83. Review.

PMID:
15222774

Supplemental Content

Support Center